Doctors test faster radiation for rare abdominal tumors
NCT ID NCT06812052
Summary
This early-phase trial is testing whether a shorter, more intense course of radiation is safe for people with retroperitoneal sarcoma, a rare cancer in the abdomen. The study will enroll 6 adults to monitor side effects like nausea and diarrhea in the first month after treatment. The goal is to see if this approach can be used before surgery to help control the tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETROPERITONEAL SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital / Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02446, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.